Melasma Block (Brightening Serum for Spots with nAHAs 5% and nTranexamic 5%) is a product provided in a ready-to-fill format. Dermatologically tested and clinically proven to lighten spots and improve skin uniformity, the product comes with complete documentation for ANVISA notification. This way, you can quickly launch a high-performance product with your brand, reducing R&D costs and time to market!

The nAHAs active ingredient contains a blend of alpha-hydroxy acids (glycolic, malic, citric, and lactic acids) encapsulated in lipid nanoparticles. Alpha-hydroxy acids (AHAs) are naturally occurring organic acids. Topical use of AHAs is indicated for the treatment of various skin issues, including age spots, acne, melasma, skin aging, among others.

The nTranexamic active ingredient, on the other hand, contains nanoencapsulated tranexamic acid. Tranexamic acid has functional brightening activity in the treatment of melasma, as it can inhibit melanin synthesis by blocking the plasminogen/plasmin pathway, preventing the interaction between melanocytes and keratinocytes.

The encapsulation of these acids allows for a more gradual and prolonged release of the encapsulated actives, reducing the burning sensation and aggressiveness of the acids in their free form.

Learn more about the benefits of the nAHAs e nTranexamic!